How Dodd was paid
$840,686 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Options | Other | Total |
|---|---|---|---|---|
| David A. DoddPresident and CEO | $387,695 | $452,991 | — | $840,686 |
| Kelly T. McKee, MDChief Medical Officer | $357,000 | $170,940 | $11,550 | $539,490 |
| Mark J. Newman, PhDChief Scientific Officer | $301,703 | $170,940 | — | $472,643 |
What changed and why
- $841KDavid A. Dodd received total compensation of $840,686 for fiscal 2025, representing an increase from $645,795 in fiscal 2024.
- $388KCompensation for the CEO in fiscal 2025 included $387,695 in base salary and $452,991 in option awards.
- $539KKelly T. McKee, MD received total compensation of $539,490 for fiscal 2025 compared to $534,969 for fiscal 2024.
- $473KMark J. Newman, PhD received total compensation of $472,643 for fiscal 2025 compared to $456,540 for fiscal 2024.
- $62.00Stock options granted to executives in fiscal 2025 vest over a three-year period and had an exercise price of $62.00.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.